Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease

Though Abl inhibitors are often successful therapies for the initial stages of chronic myelogenous leukemia (CML), refractory cases highlight the need for novel molecular insights. We demonstrate that mice deficient in the enzyme 12/15-lipoxygenase (12/15-LO) develop a myeloproliferative disorder (M...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Middleton, Melissa Kristine, Zukas, Alicia Marie, Rubinstein, Tanya, Jacob, Michele, Zhu, Peijuan, Zhao, Liang, Blair, Ian, Puré, Ellen
Формат: Artigo
Язык:Inglês
Опубликовано: The Rockefeller University Press 2006
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2118138/
https://ncbi.nlm.nih.gov/pubmed/17043146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20061444
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы